Keyphrases
3-cycle
50%
Advanced Ovarian Cancer
100%
Alopecia
25%
Area under the Curve
25%
Carboplatin
100%
Chemotherapy
25%
Complete Response Rate
25%
Cytoreductive Surgery
25%
Epithelial Ovarian Cancer
25%
Epithelial Ovarian Carcinoma
50%
Epoetin Alfa
25%
Hematotoxicity
25%
Initial Treatment
25%
Median Progression-free Survival
25%
Median Survival
25%
Neoadjuvant Chemotherapy
25%
Neuropathy
75%
Neutropenia
50%
Overall Response Rate
25%
Paclitaxel
100%
Phase II Study
50%
Postoperative Adjuvant Chemotherapy
25%
Primary Peritoneal Cancer
25%
Stage IC
25%
Stage III-IV
25%
Tubal Carcinoma
25%
Pharmacology, Toxicology and Pharmaceutical Science
Alopecia
25%
Carboplatin
100%
Carcinoma
25%
Chemotherapy
100%
Diseases
25%
Neuropathy
75%
Neutropenia
50%
Ovary Carcinoma
100%
Paclitaxel
100%
Progression Free Survival
25%
Recombinant Erythropoietin
25%
Medicine and Dentistry
Adjuvant Chemotherapy
25%
Alopecia Mucinosa
25%
Carboplatin
100%
Carcinoma
25%
Cytoreductive Surgery
25%
Diseases
25%
Krukenberg Tumor
100%
Neoadjuvant Chemotherapy
25%
Neuropathy
75%
Neutropenia
50%
Paclitaxel
100%
Progression Free Survival
25%
Recombinant Erythropoietin
25%